StonvexLoading…
StonvexStonvexStonvexCore line items from NOAH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $373.26M | $356.33M | $464.05M | $449.51M |
Operating Income | $111.06M | $86.84M | $154.64M | $157.81M |
Net Income | $79.92M | $65.14M | $142.19M | $141.59M |
EPS (Diluted) | $0.23 | $0.18 | $0.41 | $4.14 |
Total Assets | $1.68B | $1.61B | $1.79B | $1.71B |
Total Liabilities | $251.39M | $241.95M | $318.01M | $333.13M |
Cash & Equivalents | $623.60M | $523.66M | $731.30M | $638.51M |
Free Cash Flow OCF − CapEx | $120.47M | $41.81M | $163.44M | $82.67M |
Shares Outstanding | 333.37M | 330.39M | 326.31M | 313.02M |